packageRepaglinide

repaglinide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Repaglinide is an oral anti-diabetic medicine used to lower blood sugar in people with type 2 diabetes. It is authorised in the European Union and is widely used as a blood glucose-lowering drug, both alone and in combination products.

Summary written by glm-5.3-flash from Wikidata Q2195995 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:repaglinide
ATC codes:A10BX02
DrugBank:DB00912
PubChem CID:65981
ChEBI:8805
Wikidata:Q2195995
formula:C27H36N2O4
molar mass:452.595 g/mol (PubChem CID 65981)
logP:5.2 (Drugs.Common 25.09, not verified)

Metabolites

Gemfibrozil1OGlucuronidegemfibrozil 1-O-β glucuronide426.462 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
Gemfibrozil1OGlucuronidemetabolite: gemfibrozil 1-O-β glucuronide